title: [Lower limb arterial disease--nothing new since the SBU report].
authors.affiliation: Institutionen för kirurgiska vetenskaper, enheten för kirurgi, Uppsala universitet. david.bergqvist@surgsci.uu.se
authors.forename: David
authors.initials: D
authors.lastname: Bergqvist
authors.forename: Juliette
authors.initials: J
authors.lastname: Säwe
authors.forename: Eric
authors.initials: E
authors.lastname: Wahlberg
mesh_terms: D000077407:Cilostazol; D057510:Endovascular Procedures / Q000009:adverse effects / Q000379:methods; D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007383:Intermittent Claudication / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D007511:Ischemia / Q000175:diagnosis / Q000601:surgery; D007866:Leg / Q000098:blood supply; D058729:Peripheral Arterial Disease / Q000175:diagnosis / Q000601:surgery; D012307:Risk Factors; D016540:Smoking Cessation; D013777:Tetrazoles / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
chemical_list: D005343:Fibrinolytic Agents; D013777:Tetrazoles; D014665:Vasodilator Agents; D000077407:Cilostazol